HealthPrize offers a Software-as-a-Service, HIPAA-compliant platform and services designed to create digital experiences that boost patient engagement, education and medication adherence for healthcare companies and pharmaceutical brands. The company has deployed programs across primary care and specialty conditions in the U.S., and has programs in market or in development across North America, Latin America, Europe and emerging markets. Customers and strategic partners include multiple top-20 pharmaceutical companies, a major retail pharmacy chain and West Pharmaceutical Services. Led by CEO Thomas Kottler, HealthPrize intends to use recent financing to expand its team and pursue international and new vertical expansion. The company closed a Series B financing; the amount was not disclosed in the announcement. HealthPrize creates and manages customized digital patient engagement and medication-adherence programs that leverage behavioral economics, gamification, education and rewards. The platform is used across diverse medical conditions and demographic groups and currently serves global pharmaceutical customers, including several top-20 global pharma companies. Patients enrolled in HealthPrize programs show persistently high engagement and adherence rates nearly 50% higher than baseline on average. The company holds patents protecting its use of incentives, gaming dynamics, and prescription-fill verification. Management combines experience across healthcare, consumer products, gaming, software and other industries. HealthPrize plans to expand into payer and retail pharmacy markets, risk-bearing provider groups and self-insured employers, and pursue international growth.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2014